BlueCrest Capital Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
BlueCrest Capital Management's BSX.PRA Position: Q2 2023 in Review
BlueCrest Capital Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 84,381 shares — an estimated $10.2M sold.
BlueCrest Capital Management first reported a position in BSX.PRA in Q2 2020 and held it in 6 quarters. The position peaked at $10.2M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.
- BlueCrest Capital Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
- BlueCrest Capital Management sold 84,381 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $10.2M.
- BlueCrest Capital Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 6 quarters.
- BlueCrest Capital Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $10.2M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.
Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.